
Closing Bell: Agios Pharma Jumps, Rivian Tumbles, Fiserv Rises
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Griefeld, Carol Massar and Emily Graffeo
- Agios Pharmaceuticals (AGIO) shares jump as much as 15% to hit its highest intraday level since November after the biotech said the US Food and Drug Administration accepted its supplemental new drug application for mitapivat in sickle-cell disease with a priority review designation.
- Shares of Rivian…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.